News

Presentation from Småbolagsdagen 2017

Sprint Bioscience CEO Anders Åberg presented the company on Småbolagsdagen (The small enterprise day), 12 June 2017. The presentation is held in Swedish. Use this link.

News

Sprint Bioscience video awarded with a silver medal

The World Media Festival awards recognize excellence in modern communications media, and are acknowledged internationally as symbols of the highest production standards in modern communication. Award winners are among the leaders in their profession. Sprint Bioscience submitted the video “Fragments of Hope”. The video describes the company and drug development and at the gala, held…

Read more →

News

Q2 update from Analyst Group

Analyst Group published a new analysis of Sprint Bioscience: “Expecting an eventful 2017” You can download the full analysis (available in Swedish) here.

News

2017 first presentation to shareholders

  Did you miss out on the Investor AW together with Redeye last week? Now you can listen to what Sprint Bioscience CEO, Anders Åberg, presented. Use this link: The presentation is held in Swedish.

News

Film premiere at Sprint Bioscience – Fragments of hope

How does it work within a company that strives towards winning the battle against cancer by developing new drugs? In the corporate film, Fragments of Hope, you get the opportunity of getting better acquainted with Sprint Bioscience and gain insight into how the business is run. Thursday, February 23, in Gothenburg, the film about Sprint…

Read more →

News

Congratulation to the Scheele Award, Professor Charles L. Sawyers

Professor Charles L. Sawyers, professor at Memorial Sloan-Kettering Cancer Center has been named the recipient of the 2017 Scheele Award with the following motivation: “For his outstanding contribution in life science. Professor Sawyers’s work has led to insights into the molecular mechanisms that cause tumor resistance to cancer drugs which have paved the way for…

Read more →

News

New analysis with Q2 update from Analyst Group

The Nobel prize in medicine now puts autophagy inhibition and Sprint Bioscience’s VPS34 project in the spotlight. Read more about it in the latest Q2-update analysis from Analyst Group. “- One more billion-deal signed that demonstrates quality and efficiency – Qualitymarker within the industry increases the probability of success – Positive operating profit for H1 2016…

Read more →

News

Popular scientific aspects of autophagy

Since the announcement of the Nobel Prize in Medicine, the media around the world has continued to shed light on autophagy. Last week an interview with Dr Ravi Amaravadi, one of Sprint Bioscience scientific advisers, was sent in American radio. The program was dedicated to the Nobel Prize in medicine, physics and chemistry. Dr Amaravadi…

Read more →

News

Productive visit and interesting seminar on autophagy

Dr Ravi Amaravadi, a scientific advisor of Sprint Bioscience, was visiting Stockholm last week and held a seminar on the status of his research on autophagy inhibition in cancer patients. The Sprint Bioscience autophagy inhibition team also enjoyed an in-depth discussion with Dr Amaravadi on how VPS34 inhibitors could be best used in cancer treatment….

Read more →